251. New insulinomimetic zinc(II) complexes of alpha-amino acids and their derivatives with Zn(N2O2) coordination mode
- Author
-
Naohisa Yanagihara, Yutaka Yoshikawa, Eriko Ueda, Yoshitane Kojima, Yuka Suzuki, and Hiromu Sakurai
- Subjects
Blood Glucose ,Epinephrine ,chemistry.chemical_element ,Zinc ,Fatty Acids, Nonesterified ,Medicinal chemistry ,Mice ,Diabetes mellitus ,Drug Discovery ,medicine ,Adipocytes ,Animals ,Hypoglycemic Agents ,Insulin ,Oral glucose tolerance ,Amino Acids ,chemistry.chemical_classification ,Type 2 Diabetes Mellitus ,Fatty acid ,General Chemistry ,General Medicine ,Glucose Tolerance Test ,medicine.disease ,In vitro ,Amino acid ,Biochemistry ,chemistry ,Diabetes Mellitus, Type 2 ,Adrenergic alpha-Agonists ,medicine.drug - Abstract
Zinc(II) complexes of alpha-amino acids and their derivatives with a Zn(N2O2) coordination mode were found to have in vitro insulinomimetic activity as estimated with the inhibition of free fatty acid release in isolated rat adipocytes treated with epinephrine. It was revealed that the insulinomimetic activities of zinc(II) complexes with over-all stability constants (log beta) less than 10.5 are higher than those of ZnSO4 and VOSO4. The high blood glucose level of KK-Ay mice with type 2 diabetes mellitus was lowered by daily intraperitoneal injections of a zinc(II) complex, cis-[Zn(L-Thr)2(H2O)2], for 14 d. The improvement of diabetes mellitus was confirmed with the oral glucose tolerance test.
- Published
- 2001